Amiodarone in cardiac arrest — Dr. Busti breaks down the ARREST trial and what it actually means for patient outcomes in this episode of This Is Why.

When ventricular fibrillation persists after multiple shocks, what’s the next step? The ARREST trial gave us one of the first randomized answers—but understanding the why behind the results is what truly changes how you practice.

Dr. Busti walks through the evidence behind amiodarone in shock-refractory VF/pulseless VT, highlighting what improved—and what didn’t. You’ll learn how to interpret short-term survival benefits, weigh adverse effects, and apply this data within modern ACLS algorithms.

This is not just about memorizing steps—it’s about understanding the clinical impact so you can make better decisions under pressure.

Topics Covered:
- Why the ARREST trial was needed
- Trial design and patient population
- Survival to hospital admission vs meaningful outcomes
- Amiodarone benefits and limitations
- Adverse effects in cardiac arrest
- ACLS guideline integration
- Amiodarone vs lidocaine perspective
- Clinical decision-making in refractory VF
- Limitations of the ARREST trial
- What actually improves survival in cardiac arrest

Become a member (it's free!) to download the full clinical trial handout and framework below.

Chapter Table of Contents
00:00 Introduction: Refractory VFib & Pulseless VTach in Cardiac Arrest
00:38 Anthony Busti, MD, PharmD, MSc, FAHA, FNLA Introduction | This Is Why
01:12 What Was the ARREST Trial? Antiarrhythmics in Cardiac Arrest
02:00 ARREST Trial Design Explained: Amiodarone vs Placebo
03:14 Primary Endpoint: Survival to Hospital Admission With Pulse
03:56 ARREST Trial Results: Did Amiodarone Improve Survival?
04:43 Amiodarone Side Effects: Hypotension & Bradycardia Risks
05:24 How the ARREST Trial Changed ACLS Guidelines for VFib/VTach
06:16 Does Amiodarone Actually Save Lives Long-Term?
07:26 Practical ACLS Takeaways: When to Use Amiodarone in Refractory VFib
08:16 Major Limitations of the ARREST Trial Explained
08:57 Key Clinical Pearl: “Gets Patients to the Hospital, Not Necessarily Home”
09:32 Final Summary: Evidence-Based Resuscitation & Landmark Trial Review

If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#amiodarone cardiac arrest #ARREST trial #ventricular fibrillation #ACLS algorithm #Dr Busti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.